Company

Tiburio Therapeutics, Inc.

Tiburio Therapeutics, Inc. is a Cambridge, Massachusetts biotechnology company developing therapies for neurological disorders.

About

Founded by Imran Babar and based in Cambridge, Massachusetts, US, the company develops therapies for neurological conditions using a proprietary platform. On January 3, 2019, it raised USD 31 mn in Series A funding from Alexandria Venture Investments, Longitude Capital, Lundbeckfond Ventures and New Enterprise Associates.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in